OriolaCHIX:ORIOLH 46 14-Day RSI is 0.01 as of Jun. 26, 2026. GuruFocus rates CHIX:ORIOLH with a GF Score™ of 46/100 and a GF Value™ of €1.00 (Fairly Valued). The stock has 5 warning signs investors should review. Among 703 Healthcare Providers & Services companies, Oriola ranks better than 58.46% on this metric.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.
As of today (2026-06-26), Oriola's 14-Day RSI is 0.01.
The industry rank for Oriola's 14-Day RSI or its related term are showing as below:
CHIX:ORIOLh's 14-Day RSI is ranked better than 58.46% of 703
companies
in the Healthcare Providers & Services industry
Industry Median: 47.06
vs CHIX:ORIOLh: 0.01
Oriola (CHIX:ORIOLh) 14-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.
Oriola 14-Day RSI Related Terms
Oriola 14-Day RSI Competitor Comparison
For the Pharmaceutical Retailers subindustry, Oriola's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Oriola 14-Day RSI vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Oriola's 14-Day RSI distribution charts can be found below:
* The bar in red indicates where Oriola's 14-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Oriola (CHIX:ORIOLH) has a 14-Day RSI of 0.01 as of Jun. 26, 2026. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Oriola and its competitors. According to the industry distribution chart, Oriola ranks #292 out of 703 companies in the Healthcare Providers & Services industry, placing it in the top 41.5%.
Is Oriola's 14-Day RSI too high?
Oriola's current 14-Day RSI is 0.01. The Healthcare Providers & Services industry median 14-Day RSI is 47.06. Oriola's value of 0.01 is 100% below this industry median. Based on the distribution chart, Oriola ranks #292 out of 703 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Oriola has a GF Score™ of 46/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Oriola's 14-Day RSI compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Oriola ranks #292 out of 703 companies for 14-Day RSI. This puts Oriola in the upper half of its industry. The industry median 14-Day RSI is 47.06. Oriola's value of 0.01 is 100% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 14-Day RSI for a Healthcare Providers & Services company?
The median 14-Day RSI among Healthcare Providers & Services companies is 47.06, based on 703 companies in the industry. Companies in the top quartile (top 25%) have a 14-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 14-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Oriola's current 14-Day RSI of 0.01 is 100% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 14-Day RSI mean?
A high 14-Day RSI can signal that a stock is expensive relative to its fundamentals. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Oriola and its competitors. For the Healthcare Providers & Services industry, the median 14-Day RSI is 47.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Oriola's current 14-Day RSI is 0.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oriola stock overvalued right now?
Based on GuruFocus' analysis, Oriola (CHIX:ORIOLH) is currently considered Fairly Valued. The stock's GF Value™ is €1.00, compared to a current price of €0.94 — trading 6.2% below its estimated fair value. The current 14-Day RSI is 0.01 and 100% below the Healthcare Providers & Services industry median of 47.06. Oriola's overall GF Score™ is 46/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 14-Day RSI calculated?
14-Day RSI is calculated from a company's financial statements. For Oriola (CHIX:ORIOLH), the current 14-Day RSI is 0.01 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Oriola (CHIX:ORIOLH) Overvalued in 2026?
Based on GuruFocus' analysis, Oriola stock appears to be undervalued.
The current stock price of €0.94 is trading 6.2% below its estimated GF Value™ of €1.00.
GuruFocus considers Oriola to be Fairly Valued.
Key valuation signals for CHIX:ORIOLH:
14-Day RSI: 0.01
GF Value™: €1.00 vs. price of €0.94 (6.2% below fair value)
Industry Position: 100% below the Healthcare Providers & Services median (#292 of 703)
No single metric tells the full story. See the CHIX:ORIOLH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Oriola Corp is a health and wellbeing company operating in Nordic countries. It offers services such as the distribution of pharmaceuticals and other health and well-being products, services, and dose dispensing. Oriola's operations are divided into two segments which include distribution and wholesale. Geographically, the company operates in Sweden, Finland and other countries generating majority revenue from the region of Sweden.
46GF Score
Get the complete analysis for CHIX:ORIOLH
14-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:ORIOLH has been successfully added to your 